Content relating to Edwards Lifesciences transcatheter mitral and tricuspid devices is intended for European healthcare professionals. Click OK to confirm you are a healthcare professional and proceed, or click Decline to view non-device related content.
Personalised
Solutions
by Edwards Lifesciences–with the broadest portfolio of therapies
Personalised
Touch
by you, the physician–to deliver optimal care for the most patients
In collaboration with cardiologists like you, Edwards Transcatheter Mitral and Tricuspid Therapies (TMTT) group is making a meaningful mark on the lives of patients with mitral and tricuspid regurgitation.
Personalised
Solutions
by Edwards Lifesciences–with the broadest portfolio of therapies
Personalised
Touch
by you, the physician–to deliver optimal care for the most patients
Make it personal. Select which device you would like to explore first.
Stay up to date with our personalised solutions, sent directly to your inbox
Sign up now and get the latest information, news, and events on mitral and tricuspid therapies by Edwards.
Thank You
For professional use
For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.
Cardioband Systems are manufactured by Valtech Cardio Ltd. for Edwards Lifesciences.
Edwards, Edwards Lifesciences, the stylized E logo, Cardioband, PASCAL, PASCAL Ace, Valtech, and Valtech Cardio are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.
© 2021 Edwards Lifesciences Corporation. All rights reserved. PP—EU-0591 v1.0
Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com
